GlassScriptPhysician profile
Natalie P Blache
NPI 1922254192
$564.01
in general payments reported to CMS, 2019-2025
11 companies · $52.96 in 2025
The $52.96 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $12.27 · 2022: $74.15 · 2023: $146 · 2024: $139 · 2025: $52.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $157.70 | 2022-2024 | Liletta, Lo Loestrin Fe, Orilissa |
| Boston Scientific Corporation | $130.42 | 2023-2024 | Exalt Model D, Apollo Esg Nxt System |
| Allergan, INC. | $94.75 | 2019-2020 | |
| Astellas Pharma Global Development | $33.38 | 2025 | Veozah |
| Therapeuticsmd, INC. | $29.25 | 2019 | |
| Organon LLC | $29.04 | 2024 | |
| Daiichi Sankyo INC. | $26.66 | 2023 | Injectafer |
| Sage Therapeutics, LLC | $19.58 | 2025 | Zurzuvae |
| Roche Diagnostics Corporation | $15.76 | 2019 | |
| Exeltis, USA INC. | $15.68 | 2024 | Slynd |
| Duchesnay USA Incorporated | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Blache listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.